Skip to main content
. Author manuscript; available in PMC: 2016 Jan 31.
Published in final edited form as: J Neurooncol. 2014 Dec 13;121(3):627–634. doi: 10.1007/s11060-014-1680-2

Table 2.

Treatment-related toxicities, grade 2 or above

Toxicity Grade 2 Grade 3 Grade 4 Total
Hematologic
Thrombocytopenia 0 1 0 1
Leukopenia 0 2 0 2
Neutropenia 1 0 0 1
Lymphopenia 1 3 1 5
Dermatologic
Acne 4 0 0 4
Desquamation 3 0 0 3
Pruritis 0 1 0 1
Photosensitivity 0 1 0 1
Hand-foot rash 0 1 0 1
Endocrine
Hypertriglyceridemia 0 1 0 1
Hyperglycemia 1 0 0 1
Hypophosphatemia 1 3 0 4
Constitutional
Fatigue 4 2 0 6
Gastrointestinal
Anorexia 1 0 0 1
Nausea 1 0 0 1
Diarrhea 1 0 0 1
Colitis 0 1 0 1
Liver function
Elevated AST/SGOT 0 1 0 1
Vascular
Thrombosis/embolism 0 0 2 2
Other
Proteinuria 1 0 0 1
Prolonged QTc interval 0 1 0 1
Headache 0 1 0 1
Insomnia 1 0 0 1

Grade 2 toxicities listed are those that were deemed probably or definitely related to study medications by treating physicians

Grade 3 and 4 toxicities listed are those that were deemed possible, probable or definitely related to study medications by treating physicians